The Second Affiliated Hospital Of Shandong First Medical University

This study is testing whether a drug called trilaciclib can protect patients' bone marrow from damage caused by chemotherapy. It focuses on people with advanced bile duct or pancreatic cancer. The main goal is to see if it reduces severe drops in white blood cells, a common and d…

This study is testing a new combination of treatments for advanced liver cancer (hepatocellular carcinoma). It will give 41 participants a mix of two immunotherapy drugs (iparomlimab and tuvonralimab, together called QL1706), a targeted drug (lenvatinib), and a localized procedur…